{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:38Z","timestamp":1786437038227,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Rhabdomyolysis can be an uncommon complication of coronavirus disease 2019 (COVID-19) infection. However, the diagnosis of rhabdomyolysis could be easily missed due to its atypical clinical presentations. We present a patient with a history of end-stage renal disease (ESRD) who contracted COVID-19 and subsequently developed rhabdomyolysis. We discuss and share our experience in the management of this patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>An 85-year-old male with ESRD undergoing routine hemodialysis was tested positive for COVID-19. The patient had clinical symptoms of fatigue, muscle pain, and difficulty walking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>The serum creatine kinase (CK) level was markedly elevated to 32,492.9U\/L, supporting the diagnosis of rhabdomyolysis. A computed tomography scan revealed muscle injuries throughout the body, confirming the diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was managed through electrolyte corrections and continuous renal replacement therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Repeat tests showed decreased levels of serum CK and negative severe acute respiratory syndrome coronavirus 2. His clinical symptoms, including fatigue and muscle pain, had significantly improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>COVID-19 infection can cause muscle pain and fatigue, which can mask the symptoms of rhabdomyolysis. A missed diagnosis of rhabdomyolysis can be severe, especially in patients with ESRD. The serum CK level should be tested with clinical suspicion. Appropriate management, including adequate hydration and electrolyte balance, should be provided. Continuous renal replacement therapy should be considered in affected patients with renal insufficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000036360","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T22:05:54Z","timestamp":1701468354000},"page":"e36360","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Rhabdomyolysis in a patient with end-stage renal disease and SARS-CoV-2 infection: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Wenhui","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Nephrology and Oncology, The People\u2019s Hospital of Yubei District of Chongqing, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Oncology, The People\u2019s Hospital of Yubei District of Chongqing, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"You","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Oncology, The People\u2019s Hospital of Yubei District of Chongqing, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0445-7255","authenticated-orcid":false,"given":"Rui","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Oncology, The People\u2019s Hospital of Yubei District of Chongqing, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.medcle.2021.09.010","article-title":"Rhabdomyolysis: a syndrome to be considered.","volume":"158","author":"Baeza-Trinidad","year":"2022","journal-title":"Medicina Cl\u00ednica (English Edition)"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.3390\/ijms23158215","article-title":"Rhabdomyolysis-induced AKI (RIAKI) including the role of COVID-19.","volume":"23","author":"M\u0142ynarska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R4-20260811","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R5-20260811","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review.","volume":"5","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R6-20260811","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.disamonth.2020.101015","article-title":"Rhabdomyolysis.","volume":"66","author":"Cabral","year":"2020","journal-title":"Dis Month"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00415-019-09185-4","article-title":"A systematic review on the definition of rhabdomyolysis.","volume":"267","author":"Stahl","year":"2020","journal-title":"J Neurol"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13054-016-1314-5","article-title":"Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice.","volume":"20","author":"Chavez","year":"2016","journal-title":"Crit Care"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1368-5031.2005.00540.x","article-title":"Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome.","volume":"59","author":"Chen","year":"2005","journal-title":"Int J Clin Pract"},{"key":"R10-20260811","doi-asserted-by":"crossref","first-page":"e243112","DOI":"10.1136\/bcr-2021-243112","article-title":"Severe acute inflammatory myositis and rhabdomyolysis in paediatric SARS-CoV-2-associated MIS-C (multisystem inflammatory syndrome in children).","volume":"14","author":"Cassim","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R11-20260811","first-page":"1441","article-title":"Rhabdomyolysis in pediatric patients with SARS-CoV-2 infection.","volume":"9","author":"Wu","year":"2022","journal-title":"Children (Basel, Switzerland)"},{"key":"R12-20260811","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.","volume":"43","author":"Raman","year":"2022","journal-title":"Eur Heart J"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/acs.jmedchem.1c00477","article-title":"Synthetic peptides that antagonize the angiotensin-converting enzyme-2 (ACE-2) interaction with SARS-CoV-2 receptor binding spike protein.","volume":"65","author":"Sadremomtaz","year":"2021","journal-title":"J Med Chem"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-020-00165-0","article-title":"Rheumatic manifestations of COVID-19: a systematic review and meta-analysis.","volume":"4","author":"Ciaffi","year":"2020","journal-title":"BMC Rheumatol"},{"key":"R15-20260811","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","article-title":"Neuromuscular presentations in patients with COVID-19.","volume":"41","author":"Paliwal","year":"2020","journal-title":"Neurol Sci"},{"key":"R16-20260811","doi-asserted-by":"crossref","first-page":"813924","DOI":"10.3389\/fphys.2022.813924","article-title":"The musculoskeletal involvement after mild to moderate COVID-19 infection.","volume":"13","author":"Dos Santos","year":"2022","journal-title":"Front Physiol"},{"key":"R17-20260811","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2174\/1570161113666150130151839","article-title":"Drugs and Rhabdomyolysis: from Liver to kidney.","volume":"13","author":"Barbano","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"R18-20260811","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0956462414560777","article-title":"Primary HIV infection presenting as limbic encephalitis and rhabdomyolysis.","volume":"26","author":"Ferrada","year":"2015","journal-title":"Int J STD AIDS"},{"key":"R19-20260811","first-page":"58","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment.","volume":"15","author":"Torres","year":"2015","journal-title":"Ochsner J"},{"key":"R20-20260811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: rhabdomyolysis\u2013an overview for clinicians.","volume":"9","author":"Huerta-Alard\u00edn","year":"2004","journal-title":"Critical Care"},{"key":"R21-20260811","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.","volume":"18","author":"Petejova","year":"2014","journal-title":"Critical Care"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/0886022X.2022.2132170","article-title":"Earlier continuous renal replacement therapy is associated with reduced mortality in rhabdomyolysis patients.","volume":"44","author":"Li","year":"2022","journal-title":"Ren Fail"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000036360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:03:29Z","timestamp":1786435409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000036360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":22,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036360","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}